Literature DB >> 12030600

Comparison of circulating and local adipose tissue renin-angiotensin system in normotensive and hypertensive obese subjects.

E Faloia1, C Gatti, M A Camilloni, B Mariniello, C Sardu, G G M Garrapa, F Mantero, G Giacchetti.   

Abstract

The renin-angiotensin-aldosterone system (RAAS) plays a well-recognized role in the regulation of BP and in salt and water balance. Since hypertension affects a considerable proportion of obese patients, circulating RAAS has been studied in obese subjects with and without hypertension, albeit with conflicting results. Furthermore, attention has recently focused on the expression of the components of the Renin-angiotensin system (RAS) in some organs, including adipose tissue where it seems to be involved in the regulation of growth and differentiation. The aim of our study was to investigate circulating RAAS and adipose tissue RAS in obese patients with and without hypertension and in matched controls. PRA, and plasma and urinary aldosterone levels were measured in 35 obese, 30 hypertensive obese patients and in 20 controls. In addition, the expression of angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1) genes was studied in sc adipose tissue from 8 obese, 6 hypertensive obese and 6 healthy subjects. As previously demonstrated in other studies, there were no significant differences in the levels of circulating RAAS components in the 3 groups. As regards local RAS, interestingly, we found that AT1 gene was significantly more expressed in sc adipose tissue from obese patients with hypertension than in those without hypertension and controls. By contrast, AGT levels were similar in the 3 groups. Our data do not support the hypothesis of an involvement of circulating RAAS in the development of obesity-related hypertension. On the other hand, local RAS seems to be differently regulated in sc adipose tissue from obese patients with hypertension with respect to normotensive obese patients and controls.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12030600     DOI: 10.1007/BF03344010

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  37 in total

1.  Co-expression of renin-angiotensin system genes in human adipose tissue.

Authors:  S Engeli; K Gorzelniak; R Kreutz; N Runkel; A Distler; A M Sharma
Journal:  J Hypertens       Date:  1999-04       Impact factor: 4.844

Review 2.  Obesity and hypertension.

Authors:  E Faloia; G Giacchetti; F Mantero
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

Review 3.  Adipose tissue as an endocrine organ.

Authors:  G Ailhaud
Journal:  Int J Obes Relat Metab Disord       Date:  2000-06

4.  Gene expression of angiotensinogen in adipose tissue of obese patients.

Authors:  G Giacchetti; E Faloia; C Sardu; M A Camilloni; B Mariniello; C Gatti; G G Garrapa; M Guerrieri; F Mantero
Journal:  Int J Obes Relat Metab Disord       Date:  2000-06

5.  Role for aldosterone in blood pressure regulation of obese adolescents.

Authors:  A P Rocchini; V L Katch; R Grekin; C Moorehead; J Anderson
Journal:  Am J Cardiol       Date:  1986-03-01       Impact factor: 2.778

Review 6.  von Willebrand factor and its disorders: an overview of recent molecular studies.

Authors:  E G Tuddenham
Journal:  Blood Rev       Date:  1989-12       Impact factor: 8.250

7.  Rescue of angiotensinogen-knockout mice.

Authors:  J Ishida; F Sugiyama; K Tanimoto; K Taniguchi; M Syouji; E Takimoto; H Horiguchi; K Murakami; K i Yagami; A Fukamizu
Journal:  Biochem Biophys Res Commun       Date:  1998-11-27       Impact factor: 3.575

8.  Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms.

Authors:  G Nickenig; J Röling; K Strehlow; P Schnabel; M Böhm
Journal:  Circulation       Date:  1998-12-01       Impact factor: 29.690

9.  Distribution of angiotensin II receptors in rat and human adipocytes.

Authors:  D L Crandall; H E Herzlinger; B D Saunders; D C Armellino; J G Kral
Journal:  J Lipid Res       Date:  1994-08       Impact factor: 5.922

10.  Components of the renin-angiotensin system in adipose tissue: changes with maturation and adipose mass enlargement.

Authors:  J B Harp; M DiGirolamo
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1995-09       Impact factor: 6.053

View more
  25 in total

1.  Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study.

Authors:  Anand Vaidya; Bei Sun; Carol Larson; John P Forman; Jonathan S Williams
Journal:  J Clin Endocrinol Metab       Date:  2012-04-26       Impact factor: 5.958

2.  Human adipose angiotensinogen gene expression and secretion are stimulated by cyclic AMP via increased DNA cyclic AMP responsive element binding activity.

Authors:  Valérie Serazin; Esther Dos Santos; Mireille Morot; Yves Giudicelli
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

3.  [Current status of antihypertensive drug treatment in primary care practice at launch of the new renin inhibitor aliskiren (RASANT)].

Authors:  Axel Müller; Johannes Schweizer; Wilhelm Kirch; Christoph Schindler
Journal:  Med Klin (Munich)       Date:  2010-03-28

Review 4.  Control of energy balance by the brain renin-angiotensin system.

Authors:  Kristin E Claflin; Justin L Grobe
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

5.  Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension.

Authors:  A Vaidya; J P Forman; J S Williams
Journal:  J Hum Hypertens       Date:  2010-12-02       Impact factor: 3.012

Review 6.  Anti-hypertensive drug treatment of patients with and the metabolic syndrome and obesity: a review of evidence, meta-analysis, post hoc and guidelines publications.

Authors:  Jonathan G Owen; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-06       Impact factor: 5.369

Review 7.  Opposing tissue-specific roles of angiotensin in the pathogenesis of obesity, and implications for obesity-related hypertension.

Authors:  Nicole K Littlejohn; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-10-21       Impact factor: 3.619

8.  Bmal1 in Perivascular Adipose Tissue Regulates Resting-Phase Blood Pressure Through Transcriptional Regulation of Angiotensinogen.

Authors:  Lin Chang; Wenhao Xiong; Xiangjie Zhao; Yanbo Fan; Yanhong Guo; Minerva Garcia-Barrio; Jifeng Zhang; Zhisheng Jiang; Jiandie D Lin; Y Eugene Chen
Journal:  Circulation       Date:  2018-01-25       Impact factor: 29.690

9.  Oestrogen and weight loss decrease isoproterenol-induced Fos immunoreactivity and angiotensin type 1 mRNA in the subfornical organ of female rats.

Authors:  Eric G Krause; Kathleen S Curtis; Todd L Stincic; Jason P Markle; Robert J Contreras
Journal:  J Physiol       Date:  2006-03-16       Impact factor: 5.182

10.  Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.

Authors:  Rhonda Bentley-Lewis; Gail K Adler; Todd Perlstein; Ellen W Seely; Paul N Hopkins; Gordon H Williams; Rajesh Garg
Journal:  J Clin Endocrinol Metab       Date:  2007-08-28       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.